These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Past, present, and future standards for management of dyslipidemia. LaRosa JC; Gotto AM Am J Med; 2004 Mar; 116 Suppl 6A():3S-8S. PubMed ID: 15050186 [TBL] [Abstract][Full Text] [Related]
3. Lipids and CVD management: towards a global consensus. Ballantyne C; Arroll B; Shepherd J Eur Heart J; 2005 Nov; 26(21):2224-31. PubMed ID: 15972289 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of C-reactive protein as a predictor of vascular risk. Katrinchak C; Fritz K J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898 [TBL] [Abstract][Full Text] [Related]
5. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW; Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709 [TBL] [Abstract][Full Text] [Related]
6. [Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations]. Mayer O; Mayer O Vnitr Lek; 2004 Oct; 50(10):777-80. PubMed ID: 15633934 [TBL] [Abstract][Full Text] [Related]
7. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components. Ghafoorunissa Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688 [TBL] [Abstract][Full Text] [Related]
8. Screening guidelines for coronary heart disease in diabetes: current recommendations. Singh S; Duggal J; Khosla N; Arora R J Cardiometab Syndr; 2009; 4(2):107-12. PubMed ID: 19614798 [TBL] [Abstract][Full Text] [Related]
9. Treating dyslipidemia in high-risk patients: case reviews and discussion. Deedwania PC; Davidson MH; Ballantyne CM Postgrad Med; 2004 Sep; 116(3 Suppl):21-8. PubMed ID: 19667672 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol and coronary events. The current thinking. Jones PH Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618 [TBL] [Abstract][Full Text] [Related]
11. New guidelines from the National Cholesterol Education Program: what is the impact on risk assessment? Lowden JA J Insur Med; 2002; 34(1):26-30. PubMed ID: 15303591 [TBL] [Abstract][Full Text] [Related]
12. Adult treatment panel III and the management of dyslipidemia risk factors. Stein EA Postgrad Med; 2002 Oct; 112(4 Suppl):12-7. PubMed ID: 19667595 [TBL] [Abstract][Full Text] [Related]
18. Age and time need not and should not be eliminated from the coronary risk prediction models. Vasan RS; D'Agostino RB Circulation; 2005 Feb; 111(5):542-5. PubMed ID: 15699273 [No Abstract] [Full Text] [Related]
19. Prevention of coronary heart disease and the National Cholesterol Education Program. Kuller LH Circulation; 2006 Feb; 113(5):598-600. PubMed ID: 16461829 [No Abstract] [Full Text] [Related]
20. [Stratification of global cardiovascular risk according to the ESH/ESC guidelines]. Waeber B; Feihl F Rev Med Suisse; 2007 Sep; 3(124):1992-4. PubMed ID: 17955825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]